Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biohaven Ltd (NY: BHVN )

13.68 -0.35 (-2.49%)
Official Closing Price Updated: 4:10 PM EDT, Mar 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,054,468
Open 14.25
Bid (Size) 13.41 (3)
Ask (Size) 13.77 (1)
Prev. Close 14.03
Today's Range 13.27 - 14.26
52wk Range 7.100 - 152.56
Shares Outstanding 65,401,228
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million
HighlightLL Pharma out-licensed rights to its novel oral, brain-penetrating, dual inhibitor to New Haven’s Biohaven in a deal worth up to $970 million. Biohaven will have global rights to the product... 
Via Talk Markets
Analysts Holding As Pfizer Waits On Two Phase 3 Studies
Pfizer has two products with great potential, waiting on phase-3 study results. The resulting revenue increase should also improve share value. 
Via MarketBeat
Topics Bankruptcy
Exposures Financial Legal

Performance

YTD
+1.33%
+1.33%
1 Month
-10.06%
-10.06%
3 Month
+4.67%
+4.67%
6 Month
-91.00%
-91.00%
1 Year
-88.75%
-88.75%

More News

Read More
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
Via Benzinga
Jim Cramer Says This Stock Up 23% In A Month Is 'A Great Speculative Buy'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
Via Benzinga
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
Jim Cramer Says This Stock Is Dynamite: 'I Do Not Want You To Do A Thing Other Than Ride It'
Via Benzinga
How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market
Via Benzinga
$41 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying
Via Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
Via Benzinga
Moderna, Amazon, Tesla, And Other Big Gainers From Friday
Via Benzinga
Intuitive Surgical, Netflix, ASML And Other Big Gainers From Wednesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Olaplex Shares Dipped Around 57%; Here Are 75 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Via Benzinga
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Coinbase Global And 3 Other Stocks Insiders Are Buying
Via Benzinga
Biohaven Ltd. Surges 7.6%: Is This An Indication Of Further Gains?
Via Talk Markets
Pinterest, Perion Network And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Why WISeKey International Is Trading Higher By Over 20%; Here Are 29 Stocks Moving Premarket
Via Benzinga
Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.